ODAC | sciencenewsnet.in

Breaking News

Alarming study unveils how “forever chemicals” transfer from mothers to newborns

Easter Island’s ‘population crash’ never occurred, new research reveals

Chilling discovery: Cold-sensing protein may pave the way for safer pain relief

Activating molecular target reverses multiple hallmarks of aging

Cannabis use tied to increased risk of severe COVID-19

Women’s family trajectories after union dissolution: A comparative life course analysis

Educational experiences and American young adults’ childbearing goals: A research note

Family and consensual non-monogamy: Parents’ perceptions of benefits and challenges

The entrepreneurial gender gap: The role of in-group support and national embeddedness values in young women’s entrepreneurship

Empowering Older Adults: Wearable Tech Made Easier With Personalized Support

22 Jun, 2024

Recent FDA Committee Vote Could Speed Multiple Myeloma Drug Approval

May 21, 2024 sarah JonasResearch Results

An FDA committee voted unanimously last month to approve a new clinical endpoint, minimal residual disease, when evaluating proposed drugs to treat multiple myeloma. The 12-0 vote was based primarily on an analysis spearheaded by C. Ola Landgren, M.D., Ph.D., first author of a new paper published May 20 in the journal Blood.